Avalon GloboCare Corp. (ALBT)
NASDAQ: ALBT · Real-Time Price · USD
2.780
-0.040 (-1.42%)
Nov 20, 2024, 4:00 PM EST - Market closed
Company Description
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States.
The company focuses to develop diagnostics and clinical laboratory services through ownership acquisition or license rights in precision diagnostic assets, genetic testing and clinical laboratory companies through joint ventures, and share ownership structures or distribution rights.
The company was founded in 2016 and is headquartered in Freehold, New Jersey.
Avalon GloboCare Corp.
| Country | United States |
| Founded | 2014 |
| Industry | Real Estate Services |
| Sector | Real Estate |
| Employees | 5 |
| CEO | David Jin |
Contact Details
Address: 4400 Route 9 South, Suite 3100 Freehold, New Jersey 07728 United States | |
| Phone | 732 780 4400 |
| Website | avalon-globocare.com |
Stock Details
| Ticker Symbol | ALBT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001630212 |
| CUSIP Number | 05344R203 |
| ISIN Number | US05344R2031 |
| Employer ID | 47-1685128 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. David K. Jin M.D., Ph.D. | Chief Executive Officer, President and Director |
| Luisa Ingargiola | Chief Financial Officer |
| Meng Li | Chief Operating Officer and Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 18, 2024 | 8-K | Current Report |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 1, 2024 | 8-K | Current Report |
| Oct 31, 2024 | 8-K | Current Report |
| Oct 29, 2024 | 8-K | Current Report |
| Oct 25, 2024 | 8-K | Current Report |
| Oct 24, 2024 | 8-K | Current Report |
| Oct 11, 2024 | 8-K | Current Report |
| Oct 9, 2024 | 8-K | Current Report |
| Aug 28, 2024 | DEF 14A | Other definitive proxy statements |